-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rongliflozin in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rongliflozin in Type 2 Diabetes report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rongliflozin in Type 2 Diabetes Drug Details: Rongliflozin (HEC-44616) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – E-7130 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - E-7130 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.E-7130 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRX-012 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRX-012 in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRX-012 in Alzheimer's Disease Drug Details: PRX-012 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ondansetron Hydrochloride Cr in Irritable Bowel Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ondansetron Hydrochloride Cr in Irritable Bowel Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Ondansetron Hydrochloride Cr in Irritable Bowel Syndrome Drug Details:Ondansetron hydrochloride...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Clarithromycin + Clofazimine + Rifabutin) in Crohn’s Disease (Regional Enteritis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Clarithromycin + Clofazimine + Rifabutin) in Crohn's Disease (Regional Enteritis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.(Clarithromycin + Clofazimine + Rifabutin) in Crohn's...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SAR-442257 in Refractory Multiple Myeloma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. SAR-442257 in Refractory Multiple Myeloma Drug Details: SAR-442257 is under development for the treatment of...
-
Product Insights
Vistry Group – Redhill Residential Community – Telford and Wrekin
Equip yourself with the essential tools needed to make informed and profitable decisions with our Vistry Group - Redhill Residential Community - Telford and Wrekin report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Solum Regen – Redhill Railway Station Mixed-Use Development – Surrey
Equip yourself with the essential tools needed to make informed and profitable decisions with our Solum Regen - Redhill Railway Station Mixed-Use Development - Surrey report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Company Profile
RedHill Biopharma Ltd – Company Profile
RedHill Biopharma Ltd (RedHill) is a specialty biopharmaceutical company that develops and commercializes therapeutics for gastrointestinal (GI) diseases and cancer. The company’s commercial product portfolio consists of branded prescription drugs including a combination of omeprazole, amoxicillin and rifabutin omeprazole; naloxegol; and rifamycin. RedHill is investigating its pipeline candidates for the treatment of Crohn's disease, non-tuberculous mycobacterial infection (NTM) infections, gastroenteritis, gastritis, irritable bowel syndrome with diarrhea (IBS-D), bowel cleanser, cancer and novel coronavirus disease (COVID-19). The company has a subsidiary...
Add to Basket -
Company Profile
Go-Ahead Group Plc – Company Profile
Go-Ahead Group plc (Go-Ahead) is a provider of passenger transportation services. The company offers transport services through various means of transport such as buses and trains. It provides bus services in London, the South-East, Brighton, Oxford, East Anglia, Plymouth, Southern and North-East England for Transport for London (TFL). The company provides also metrobuses services in Crawley, Horsham, East Grinstead, Redhill, and Reigate. It operates rails services in Norway, and Germany. Go-Ahead provides train services through Govia Thameslink Railway such as,...
Add to Basket